260 related articles for article (PubMed ID: 20125127)
1. The -A2518G polymorphism of monocyte chemoattractant protein-1 is associated with Crohn's disease.
Palmieri O; Latiano A; Salvatori E; Valvano MR; Bossa F; Latiano T; Corritore G; di Mauro L; Andriulli A; Annesec V
Am J Gastroenterol; 2010 Jul; 105(7):1586-94. PubMed ID: 20125127
[TBL] [Abstract][Full Text] [Related]
2. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
[TBL] [Abstract][Full Text] [Related]
3. The 14-bp deletion polymorphism in the HLA-G gene displays significant differences between ulcerative colitis and Crohn's disease and is associated with ileocecal resection in Crohn's disease.
Glas J; Török HP; Tonenchi L; Wetzke M; Beynon V; Teshome MY; Cotofana S; Schiemann U; Griga T; Klein W; Epplen JT; Folwaczny C; Folwaczny M; Mussack T; Weiss EH
Int Immunol; 2007 May; 19(5):621-6. PubMed ID: 17446213
[TBL] [Abstract][Full Text] [Related]
4. Variants of OCTN1-2 cation transporter genes are associated with both Crohn's disease and ulcerative colitis.
Palmieri O; Latiano A; Valvano R; D'Incà R; Vecchi M; Sturniolo GC; Saibeni S; Peyvandi F; Bossa F; Zagaria C; Andriulli A; Devoto M; Annese V
Aliment Pharmacol Ther; 2006 Feb; 23(4):497-506. PubMed ID: 16441470
[TBL] [Abstract][Full Text] [Related]
5. -137 (G/C) IL-18 promoter polymorphism in patients with inflammatory bowel disease.
Haas SL; Andreas Koch W; Schreiber S; Reinhard I; Koyama N; Singer MV; Böcker U
Scand J Gastroenterol; 2005 Dec; 40(12):1438-43. PubMed ID: 16316892
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of the TNF gene and the TNF receptor superfamily member 1B gene are associated with susceptibility to ulcerative colitis and Crohn's disease, respectively.
Sashio H; Tamura K; Ito R; Yamamoto Y; Bamba H; Kosaka T; Fukui S; Sawada K; Fukuda Y; Tamura K; Satomi M; Shimoyama T; Furuyama J
Immunogenetics; 2002 Mar; 53(12):1020-7. PubMed ID: 11904678
[TBL] [Abstract][Full Text] [Related]
7. The contribution of OCTN1/2 variants within the IBD5 locus to disease susceptibility and severity in Crohn's disease.
Noble CL; Nimmo ER; Drummond H; Ho GT; Tenesa A; Smith L; Anderson N; Arnott ID; Satsangi J
Gastroenterology; 2005 Dec; 129(6):1854-64. PubMed ID: 16344054
[TBL] [Abstract][Full Text] [Related]
8. Familial expression of anti-Saccharomyces cerevisiae Mannan antibodies in Crohn's disease and ulcerative colitis: a GISC study.
Annese V; Andreoli A; Andriulli A; Dinca R; Gionchetti P; Latiano A; Lombardi G; Piepoli A; Poulain D; Sendid B; Colombel JF
Am J Gastroenterol; 2001 Aug; 96(8):2407-12. PubMed ID: 11513182
[TBL] [Abstract][Full Text] [Related]
9. The combination of polymorphisms within MCP-1 and IL-1beta associated with ulcerative colitis.
Li KS; Wang BY; Liu SY; Yao SP; Guo L; Mao DW
Int J Immunogenet; 2009 Jun; 36(3):135-9. PubMed ID: 19392835
[TBL] [Abstract][Full Text] [Related]
10. IL-1 receptor antagonist (IL-1Ra) gene polymorphism in patients with inflammatory bowel disease in India.
Mittal RD; Bid HK; Ghoshal UC
Scand J Gastroenterol; 2005 Jul; 40(7):827-31. PubMed ID: 16109659
[TBL] [Abstract][Full Text] [Related]
11. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.
Cantor MJ; Nickerson P; Bernstein CN
Am J Gastroenterol; 2005 May; 100(5):1134-42. PubMed ID: 15842590
[TBL] [Abstract][Full Text] [Related]
12. Evidence for association of OCTN genes and IBD5 with ulcerative colitis.
Waller S; Tremelling M; Bredin F; Godfrey L; Howson J; Parkes M
Gut; 2006 Jun; 55(6):809-14. PubMed ID: 16361305
[TBL] [Abstract][Full Text] [Related]
13. The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
Latiano A; Palmieri O; Valvano MR; D'Incà R; Caprilli R; Cucchiara S; Sturniolo GC; Bossa F; Andriulli A; Annese V
Aliment Pharmacol Ther; 2008 Feb; 27(3):241-8. PubMed ID: 17944996
[TBL] [Abstract][Full Text] [Related]
14. Novel genetic risk markers for ulcerative colitis in the IL2/IL21 region are in epistasis with IL23R and suggest a common genetic background for ulcerative colitis and celiac disease.
Glas J; Stallhofer J; Ripke S; Wetzke M; Pfennig S; Klein W; Epplen JT; Griga T; Schiemann U; Lacher M; Koletzko S; Folwaczny M; Lohse P; Göke B; Ochsenkühn T; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2009 Jul; 104(7):1737-44. PubMed ID: 19455118
[TBL] [Abstract][Full Text] [Related]
15. DLG5 variants in inflammatory bowel disease.
Büning C; Geerdts L; Fiedler T; Gentz E; Pitre G; Reuter W; Luck W; Buhner S; Molnar T; Nagy F; Lonovics J; Dignass A; Landt O; Nickel R; Genschel J; Lochs H; Schmidt HH; Witt H
Am J Gastroenterol; 2006 Apr; 101(4):786-92. PubMed ID: 16494592
[TBL] [Abstract][Full Text] [Related]
16. Serum angiotensin I-converting enzyme is reduced in Crohn's disease and ulcerative colitis irrespective of genotype.
Matsuda T; Suzuki J; Furuya K; Masutani M; Kawakami Y
Am J Gastroenterol; 2001 Sep; 96(9):2705-10. PubMed ID: 11569699
[TBL] [Abstract][Full Text] [Related]
17. The functional genetic variation in the PTPN22 gene has a negligible effect on the susceptibility to develop inflammatory bowel disease.
Martín MC; Oliver J; Urcelay E; Orozco G; Gómez-Garcia M; López-Nevot MA; Piñero A; Brieva JA; de la Concha EG; Nieto A; Martín J
Tissue Antigens; 2005 Oct; 66(4):314-7. PubMed ID: 16185327
[TBL] [Abstract][Full Text] [Related]
18. Lack of association between IBD5 and Crohn's disease in Japanese patients demonstrates population-specific differences in inflammatory bowel disease.
Tosa M; Negoro K; Kinouchi Y; Abe H; Nomura E; Takagi S; Aihara H; Oomori S; Sugimura M; Takahashi K; Hiwatashi N; Takahashi S; Shimosegawa T
Scand J Gastroenterol; 2006 Jan; 41(1):48-53. PubMed ID: 16373276
[TBL] [Abstract][Full Text] [Related]
19. Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases.
Heresbach D; Alizadeh M; Dabadie A; Le Berre N; Colombel JF; Yaouanq J; Bretagne JF; Semana G
Am J Gastroenterol; 1997 Jul; 92(7):1164-9. PubMed ID: 9219791
[TBL] [Abstract][Full Text] [Related]
20. Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease--an IG-IBD study.
Annese V; Lombardi G; Perri F; D'Incà R; Ardizzone S; Riegler G; Giaccari S; Vecchi M; Castiglione F; Gionchetti P; Cocchiara E; Vigneri S; Latiano A; Palmieri O; Andriulli A
Am J Gastroenterol; 2005 Jan; 100(1):84-92. PubMed ID: 15654786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
